PRESS & NEWS
CurePSP Ask the Scientist: September 3, 2020
The next Ask the Scientist webinar will feature Michelle Troche, Ph.D., discussing developing treatments for swallowing and communication deficits in progressive supranuclear palsy (PSP). It will take place on Thursday, September 3, 2020, at 12:00 p.m. Eastern Daylight Time (9 a.m. PDT) Dr. Troche currently serves as an associate professor of speech and language pathology in…
The next Ask the Scientist webinar will feature Michelle Troche, Ph.D., discussing developing treatments for swallowing and communication deficits in progressive supranuclear palsy (PSP). It will take place on Thursday, September 3, 2020, at 12:00 p.m. Eastern Daylight Time (9 a.m. PDT)
Dr. Troche currently serves as an associate professor of speech and language pathology in the Communication Sciences and Disorders Program, Department of Biobehavioral Sciences at Teachers College, Columbia University. She also holds adjunct positions in the Departments of Neurology and Otolaryngology, and she directs and is the principal investigator for the college’s Laboratory for the Study of Upper Airway Dysfunction.
This webinar is technical in nature and is intended for research and healthcare professionals. Any medications that are referred to in this presentation should not be tried unless under the supervision of a licensed professional.
Dr. Troche’s research is aimed at developing robust evaluation and treatment techniques for dystussia (disordered cough) and dysphagia (swallowing difficulties). Her research has been funded by the National Institutes of Health (NIH), Michael J. Fox Foundation, and National Ataxia Foundation. In 2016, she was awarded a CurePSP Venture Grant supported by The Jasperson Legacy Fund.
CurePSP, Inc. is a nonprofit organization (501 (c)(3) organization) working to increase awareness, advocate for patients and families, and fund research for devastating prime of life neurodegenerative diseases, including progressive supranuclear palsy (PSP). Since 1990, it has provided funding to more than 200 researchers for a cumulative investment of $20 million. CurePSP's objective is to provide scientists with seed funding opportunities so they can develop the necessary proof of concept to validate innovative ideas and qualify for larger funding sources. Funds are awarded to researchers focusing on the underlying molecular and cellular mechanisms of PSP, CBD, and other neurodegenerative disorders. The organization also aims to enable researchers to focus on translational clinical studies involving patients.
Together we can find a cure for ftd
The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.
Your privacy is important! We promise to protect it. We will not share your contact information.